These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 1279364)
1. Risk factors for hepatitis C virus infection in blood donors: a case-control study. Kaldor JM; Archer GT; Buring ML; Ismay SL; Kenrick KG; Lien AS; Purusothaman K; Tulloch R; Bolton WV; Wylie BR Med J Aust; 1992 Aug; 157(4):227-30. PubMed ID: 1279364 [TBL] [Abstract][Full Text] [Related]
2. Risk factor exposure among hepatitis C virus RNA positive Swedish blood donors--the role of parenteral and sexual transmission. Shev S; Hermodsson S; Lindholm A; Malm E; Widell A; Norkrans G Scand J Infect Dis; 1995; 27(2):99-104. PubMed ID: 7544914 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of hepatitis C virus antibodies in Sydney blood donors. Archer GT; Buring ML; Clark B; Ismay SL; Kenrick KG; Purusothaman K; Kaldor JM; Bolton WV; Wylie BR Med J Aust; 1992 Aug; 157(4):225-7. PubMed ID: 1279363 [TBL] [Abstract][Full Text] [Related]
4. Clinical assessment and incidence of hepatitis C RNA in 50 consecutive RIBA-positive volunteer blood donors. McCaughan GW; McGuinness PH; Bishop GA; Painter DM; Lien AS; Tulloch R; Wylie BR; Archer GT Med J Aust; 1992 Aug; 157(4):231-3. PubMed ID: 1279365 [TBL] [Abstract][Full Text] [Related]
5. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513 [TBL] [Abstract][Full Text] [Related]
6. A high risk of hepatitis C infection among Egyptian blood donors: the role of parenteral drug abuse. Bassily S; Hyams KC; Fouad RA; Samaan MD; Hibbs RG Am J Trop Med Hyg; 1995 Jun; 52(6):503-5. PubMed ID: 7541968 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey. Serfaty L; Giral P; Elghouzzi MH; Jullien AM; Poupon R Hepatology; 1993 Feb; 17(2):183-7. PubMed ID: 8381381 [TBL] [Abstract][Full Text] [Related]
8. Risk factors and seroprevalence of hepatitis C virus antibody among blood donors in Lagos. Balogun TM; Akinsete I; Durosinmi MA Niger Postgrad Med J; 2012 Mar; 19(1):36-9. PubMed ID: 22430600 [TBL] [Abstract][Full Text] [Related]
9. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Esteban JI; López-Talavera JC; Genescà J; Madoz P; Viladomiu L; Muñiz E; Martin-Vega C; Rosell M; Allende H; Vidal X Ann Intern Med; 1991 Sep; 115(6):443-9. PubMed ID: 1651674 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for hepatitis C virus infection. A case-control study of blood donors in the Trent Region (UK). Neal KR; Jones DA; Killey D; James V Epidemiol Infect; 1994 Jun; 112(3):595-601. PubMed ID: 8005225 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for hepatitis C infection among adult patients in Kedah state, Malaysia: A case-control study. Mohd Suan MA; Said SM; Lim PY; Azman AZF; Abu Hassan MR PLoS One; 2019; 14(10):e0224459. PubMed ID: 31661525 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro. Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study. Alavian SM; Gholami B; Masarrat S J Gastroenterol Hepatol; 2002 Oct; 17(10):1092-7. PubMed ID: 12201870 [TBL] [Abstract][Full Text] [Related]
14. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery. García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for hepatitis C virus infection among blood donors in Georgia. Zaller N; Nelson KE; Aladashvili M; Badridze N; del Rio C; Tsertsvadze T Eur J Epidemiol; 2004; 19(6):547-53. PubMed ID: 15330127 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for hepatitis C virus infection among blood donors in northern Thailand. Thaikruea L; Thongsawat S; Maneekarn N; Netski D; Thomas DL; Nelson KE Transfusion; 2004 Oct; 44(10):1433-40. PubMed ID: 15383015 [TBL] [Abstract][Full Text] [Related]
18. [ALAT and viral RNA as risk factors in 68 blood donors with anti-hepatitis C antibodies]. Tullen E; De Saussure P; Soulier-Lauper M Schweiz Med Wochenschr; 1993 Jan; 123(3):57-61. PubMed ID: 7678939 [TBL] [Abstract][Full Text] [Related]
19. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria. Erhabor O; Ejele OA; Nwauche CA Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of anti-HCV and risk factors for hepatitis C virus infection in healthy pregnant women. Marranconi F; Fabris P; Stecca C; Zampieri L; Bettini MC; Di Fabrizio N; de Lalla F Infection; 1994; 22(5):333-7. PubMed ID: 7531180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]